KPC Pharmaceuticals Inc - Asset Resilience Ratio
KPC Pharmaceuticals Inc (600422) has an Asset Resilience Ratio of 7.65% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 600422 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2025)
This chart shows how KPC Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of KPC Pharmaceuticals Inc.
Liquid Assets Composition Over Time
This chart breaks down KPC Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 600422 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥839.72 Million | 7.65% |
| Total Liquid Assets | CN¥839.72 Million | 7.65% |
Asset Resilience Insights
- Limited Liquidity: KPC Pharmaceuticals Inc maintains only 7.65% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
KPC Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio
Compare KPC Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
Drug Manufacturers - Specialty & Generic | 2.79% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 2.51% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
Drug Manufacturers - Specialty & Generic | 0.97% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for KPC Pharmaceuticals Inc (2004–2025)
The table below shows the annual Asset Resilience Ratio data for KPC Pharmaceuticals Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.42% | CN¥1.11 Billion ≈ $162.28 Million |
CN¥11.77 Billion ≈ $1.72 Billion |
+5.68pp |
| 2024-12-31 | 3.74% | CN¥471.28 Million ≈ $68.96 Million |
CN¥12.61 Billion ≈ $1.85 Billion |
-1.17pp |
| 2023-12-31 | 4.91% | CN¥603.80 Million ≈ $88.35 Million |
CN¥12.30 Billion ≈ $1.80 Billion |
+1.52pp |
| 2022-12-31 | 3.39% | CN¥319.40 Million ≈ $46.74 Million |
CN¥9.43 Billion ≈ $1.38 Billion |
+1.58pp |
| 2021-12-31 | 1.80% | CN¥160.50 Million ≈ $23.49 Million |
CN¥8.89 Billion ≈ $1.30 Billion |
-2.32pp |
| 2020-12-31 | 4.12% | CN¥334.76 Million ≈ $48.99 Million |
CN¥8.12 Billion ≈ $1.19 Billion |
+1.28pp |
| 2019-12-31 | 2.84% | CN¥210.90 Million ≈ $30.86 Million |
CN¥7.43 Billion ≈ $1.09 Billion |
+1.30pp |
| 2018-12-31 | 1.54% | CN¥106.00 Million ≈ $15.51 Million |
CN¥6.89 Billion ≈ $1.01 Billion |
-8.95pp |
| 2017-12-31 | 10.49% | CN¥665.00 Million ≈ $97.31 Million |
CN¥6.34 Billion ≈ $927.47 Million |
-1.06pp |
| 2016-12-31 | 11.55% | CN¥624.00 Million ≈ $91.31 Million |
CN¥5.40 Billion ≈ $790.52 Million |
-3.22pp |
| 2015-12-31 | 14.77% | CN¥730.80 Million ≈ $106.94 Million |
CN¥4.95 Billion ≈ $724.09 Million |
+11.13pp |
| 2014-12-31 | 3.64% | CN¥110.00 Million ≈ $16.10 Million |
CN¥3.02 Billion ≈ $442.52 Million |
+3.59pp |
| 2004-12-31 | 0.04% | CN¥500.00K ≈ $73.17K |
CN¥1.17 Billion ≈ $171.49 Million |
-- |
About KPC Pharmaceuticals Inc
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, ant… Read more